The new administration’s policies are reshaping the healthcare landscape, driving renewed focus on value, evidence and operational agility.

ST. LOUIS – NOV. 10, 2025 – Numerof & Associates, a leading strategy and implementation consultancy focused on healthcare organizations navigating industry-wide transition, today released its 2026 Healthcare Industry Outlooks, offering an integrated view of the challenges and opportunities facing the pharmaceutical, healthcare delivery, health insurance and medical device sectors in the year ahead.

The firm’s annual outlooks, published as a series of infographics and executive briefs, depict an industry in the midst of rapid transformation. From drug pricing pressures and new tariffs under the Trump administration to reimbursement cuts and policy uncertainty in healthcare delivery, every corner of the ecosystem faces mounting demands for transparency, accountability and cost containment.

“The healthcare sector is entering 2026 amid a perfect storm of political, financial and operational pressures,” said Rita Numerof, PhD, president of Numerof & Associates. “Across the board, organizations are being forced to adapt. To succeed, they must fundamentally rethink their business models to demonstrate value, manage risk and improve outcomes.”

Key Findings by Sector

Pharmaceuticals

Numerof’s Global Pharma Outlook points to increased scrutiny from Washington, as the new administration demands drug price cuts and reshoring of manufacturing. With more than $200 billion in revenue at risk from patent cliffs by 2028, the report urges manufacturers to accelerate R&D, strengthen evidence generation and redesign commercial models to meet global pricing and access challenges.

Healthcare Delivery

The U.S. Healthcare Delivery Outlook highlights the financial strain on hospitals from inflation, labor shortages and declining reimbursement. With the administration moving to reduce Medicare eligibility and reform 340B pricing, the report anticipates greater emphasis on direct contracting, efficiency and digital engagement. Forward-leaning providers are expected to differentiate through measurable outcomes and value-based models.

Health Insurance

The U.S. Health Insurance Outlook projects intensifying competition from employer partnerships and direct-to-consumer models that bypass traditional insurers. As political and legislative uncertainty persists, payers will need to demonstrate value to plan sponsors and consumers, expand risk-based contracting and invest in AI and analytics to manage cost and performance.

Medical Devices

The Global Medical Device Outlook underscores both promise and pressure: demand for innovative technologies remains strong, but payers and regulators worldwide are raising the bar. Success in 2026 will require alignment of R&D, Medical Affairs and Commercial functions, as well as an emphasis on data-based economic and clinical value narratives that resonate with key stakeholders.

“Every part of the healthcare ecosystem is under pressure to prove its value,” said Michael Abrams, managing partner of Numerof & Associates. “Policy shifts are accelerating the move toward transparency and accountability, while cost pressures and competition are forcing companies to rethink the fundamentals of how they operate. The organizations that thrive will be those that pair strategic agility with the operational discipline to execute change.”

The full 2026 Healthcare Industry Outlooks are available for download at nai-consulting.com.

About Numerof & Associates
Numerof & Associates is a strategy consulting firm that develops customized, market-based solutions for the strategic and operational challenges of organizations in industries undergoing significant transition. Working globally across the healthcare industry with clients in pharmaceuticals, medical devices and diagnostics, payers, and healthcare delivery, Numerof brings a unique cross-disciplinary approach to a broad range of engagements designed to sharpen strategic focus, increase revenues, reduce costs and risk, and enhance customer value.

Visit nai-consulting.com and connect with us on LinkedIn and X (Twitter).

Media Contact:
Jamie Shearer
Account Executive, Pinkston
571.405.1606
numerof@pinkston.co